Clinical Trial Update: The AVIATOR Study: Trastuzumab and Vinorelbine With Avelumab OR Avelumab & Utomilumab in Advanced HER2+ Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 AVIATOR study evaluates trastuzumab and vinorelbine with either avelumab or utomilumab in advanced HER2-positive breast cancer; results were posted in 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Avelumab (avelumab)
• HERCEPTIN (trastuzumab)
• Navelbine (vinorelbine)
• Utomilumab (utomilumab)

Snippet

Sponsor: Adrienne G. Waks | Conditions: Breast Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2024-04-18